Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
270 Leser
Artikel bewerten:
(1)

Neelam Sharma Joins K2 Integrity as Global Head of Business Development and Sales

Finanznachrichten News

Experienced Risk and Regulatory Executive to Develop New Innovative Solutions and Expand Client Relationships

NEW YORK, Dec. 9, 2021 /PRNewswire/ -- K2 Integrity today announced Neelam Sharma has joined the firm as Global Head of Business Development and Sales. As part of the firm's global leadership team, Ms. Sharma will be responsible for creating and shaping K2 Integrity's suite of products and services to deliver cutting-edge digital solutions for the firm's growing global client base.

"When it comes to understanding the unique needs of our client base, Neelam's vision is second to none," said Andrew Rabinowitz, Co-CEO, K2 Integrity. "Neelam's skill set and expertise will complement the existing strengths of our practitioners and corporate center. Our clients-and our business-will benefit not just from her ability to create systems to streamline our business functions, but also from her experience as a practitioner and her deep understanding of client needs. We are happy to have her on board."

"I am thrilled to join the world-class team at K2 Integrity, in a role that combines my background and experience solving complex problems, managing risk, and expanding client relationships," said Ms. Sharma. "In an increasingly competitive landscape, it is critical for organizations to establish and differentiate their value for clients across the globe. Working alongside Andrew, Jeremy Kroll, and the K2 Integrity team, we will create new value propositions for our business and our clients that drive the future of risk management."

Prior to joining K2 Integrity, Ms. Sharma spent over a decade at PwC in various strategic roles, most recently serving as a director in the firm's Risk and Regulatory Data & Technology practice. At PwC, she supported leading financial services firms with their digital transformations and digital risk and regulatory systems. Ms. Sharma received a B.A. and an M.P.A. from Pace University; a Certificate in Essentials of Marketing from the University of Pennsylvania's Wharton School; a Certification in Business Analytics from Cornell University; and a Chief Risk Officer Certification from Carnegie Mellon University. Additionally, Ms. Sharma served on the governance committee and as project leader for the Digital Transformation and Innovation Center at Carnegie Mellon University, where she managed emerging technology projects. Learn more about Neelam Sharma.

About K2 Integrity

K2 Integrity is the preeminent risk, compliance, investigations, and monitoring firm-built by industry leaders, driven by interdisciplinary teams, and supported by cutting-edge technology to safeguard clients' operations, reputations, and economic security. The firm helps clients understand and manage risk so they can lead with confidence in a complex world-and build organizations that are safer, more transparent, and more resilient. By encouraging and enabling organizations to act with integrity, we aim to increase trust in institutions and promote prosperity and growth throughout the world.

K2 Integrity represents the merger of K2 Intelligence, founded by Jeremy M. Kroll and Jules B. Kroll, the originator of the modern corporate investigations industry, and Financial Integrity Network (FIN), founded by Juan Zarate and Chip Poncy, former senior Treasury and U.S. government officials responsible for helping shape the modern AML/CFT regime.

To learn more about how K2 Integrity is revolutionizing the management of risk, visit www.k2integrity.com, or follow us on Twitter or LinkedIn.

CONTACT:
Lindsay Sweeney
Senior Manager, Communications
lsweeney@k2integrity.com
917.243.7395

Logo - https://mma.prnewswire.com/media/930510/K2_Integrity_Logo.jpg

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.